A Prospective Study on the Epidemiology of Febrile Episodes during Chemotherapy-Induced Neutropenia in Children with Cancer or after Hemopoietic Stem Cell Transplantation
Clinical Infectious Diseases2007Vol. 45(10), pp. 1296–1304
Citations Over TimeTop 10% of 2007 papers
Elio Castagnola, V. Fontana, Ilaria Caviglia, Silvia Caruso, Maura Faraci, Francesca Fioredda, Maria Luisa Garrè, C. Moroni, Massimo Conte, Giuseppe Losurdo, Francesca Scuderi, Roberto Bandettini, Paolo Tomà, Claudio Viscoli, Riccardo Haupt
Abstract
The overall incidence of febrile neutropenia and severe infectious complications in children with cancer is low, with differences according to the aggressiveness of chemotherapy. This fact must be considered when designing clinical trials on the management of infectious complications in children with cancer.
Related Papers
- → agr dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci(2012)38 cited
- → Advances in the treatment of neutropenia(2009)36 cited
- → Febrile neutropenia in patients with hematological malignancies - definition, diagnosis and management(2022)1 cited
- [Nosocomial bacteremia].(2006)
- [Bacteremia during the course of Salmonella gastroenteritis].(1997)